Search filters

List of works by David F Stojdl

Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain

scientific article published on 15 September 2017

An integrated stress response regulates amino acid metabolism and resistance to oxidative stress

scientific article (publication date: March 2003)

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy

scientific article

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

scientific article published on January 2007

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection ⬇️

article

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.

scholarly article

Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

scientific article published on 07 August 2019

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.

scientific article

Correction for Tesfay et al., Vesiculovirus Neutralization by Natural IgM and Complement.

scientific article published on 12 January 2015

Customized Viral Immunotherapy for HPV-Associated Cancer

scientific article published on 14 September 2017

Development and applications of oncolytic Maraba virus vaccines

Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide

scientific article published on 7 April 2009

Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis

scientific article published on 23 September 2015

Fighting Fire with Fire: Rewiring Tumor Cells for Oncolytic Virotherapy ⬇️

scientific article published on March 1, 2012

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Getting oncolytic virus therapies off the ground

scientific article published in July 2003

Going viral with cancer immunotherapy

scientific article

Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.

scientific article

High-throughput screening to enhance oncolytic virus immunotherapy

scientific article

Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.

scientific article

Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease

scientific article

Maraba virus as a potent oncolytic vaccine vector

scientific article published on 25 October 2013

Model-based rational design of an oncolytic virus with improved therapeutic potential.

scientific article published in January 2013

Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses ⬇️

scientific article published on December 26, 2012

NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine

scientific article published on 3 February 2017

Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum.

scientific article

Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model

scientific article published on 10 December 2016

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

article

Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency

scientific article published on 8 May 2014

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

scientific article

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

scientific article published on 30 August 2017

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

scientific article

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

scholarly article by Matthew J Atherton et al published 2018 in OncoImmunology

Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis

scientific article published on 28 August 2013

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

scientific article published on 18 December 2018

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

scientific article

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation

scientific article published on 16 April 2008

Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancy

scientific article published on September 2004

Vesicular stomatitis virus: re-inventing the bullet

scientific article published on May 2004

Vesiculovirus neutralization by natural IgM and complement

scientific article published on 19 March 2014

Virus therapy for cancer.

scientific article published on November 2014

Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death.

scientific article

Paulina is supported by:

About Paulina

Help